V-PPRN Launches Study On Employment and Income

The Vasculitis Patient-Powered Research Network (V-PPRN) is a team of patients with vasculitis, caregivers, researchers, data specialists, and providers on a daily mission to share and learn from one another with a vision for the future in clinical vasculitis research.

The V-PPRN is currently conducting the VascWork study in partnership with the Vasculitis Clinical Research Consortium (VCRC).

The Impact of Vasculitis on Employment and Income (VascWork) Study

VascWorkWork disability associated with rheumatic diseases accounts for an important part of the costs of these conditions, in addition to direct treatment costs, especially with biological agents.  Interest has been growing in studying work disability associated with rheumatoid arthritis, but only a few studies have investigated vasculitis.

The purpose of this study is to learn about the impact of vasculitis on employment and income in patients with different systemic vasculitides.  Although much progress has been made towards finding better medical therapies to treat vasculitis, patients often must manage substantial disease and treatment burdens.  Patients with systemic vasculitis may have high rates of work disability and significant loss of personal income from employment.

The study is being conducted by the VCRC and led by Dr. Christian Pagnoux, from Mount Sinai Hospital, in Toronto, Canada.  He is collaborating with Dr. Lillian Barra of the University of Western Ontario, in London, Canada along with colleagues at the University of South Florida.

 

WHAT WILL THE STUDY ASK?

Employment Status:  Do patients have to take a prolonged sick leave?
Work Productivity:  How many patients have to adjust their work because of the physical demands of the job?
Income:  How many patients have a loss of income following the diagnosis of their disease?

Click here to learn more about the V-PPRN and to participate in the VascWork study.

 

WHY PARTICIPATE IN THE VASCWORK STUDY?

Hear from patients just like you about why it is important to participate in this study.

Fave_Icon_16x16

Vasculitis Foundation

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.


Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine more »

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »

Brandon Hudgins to Receive NORD Rare Impact Award at May 18th Ceremony

On  Thursday, May 18,  Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award.   The VF  nominated Brandon, a record-breaking, elite runner, for his work raising awareness about more »


Vasculitis Update 2017 CME Course: Chicago, June 24

The Vasculitis Foundation is pleased to present the 2017 Vasculitis Update CME Course for health care professionals in partnership with Northwestern Division of Rheumatology on Saturday, June 24, 2017 from 7:45 more »

Main Line Health Medical Professional Wins National Award for Early Diagnosis of Rare Disease

The Vasculitis Foundation (VF) announces the winner of its 2017 Recognizing Excellence in Diagnostics (RED) Award.  The V-RED Award is presented annually to a medical professional who made a quick diagnosis of more »